Pune, Jan. 05, 2024 (GLOBE NEWSWIRE) -- According to the latest report published by Growth Plus Reports, the global Plasma Fractionation Market is expected to clock US$ 54.37 billion by 2031 and to grow at a CAGR of 6.9% during the forecast period.
The Plasma Fractionation Market is witnessing significant strides, driving innovations in the processing of plasma to produce essential therapeutic products. This press release aims to spotlight key developments, breakthroughs, and the dynamic landscape of the Plasma Fractionation Market.
Get a Sample Copy of the Research Report: https://www.growthplusreports.com/inquiry/request-sample/plasma-fractionation-market/8505
Plasma Fractionation Market Scope
| Report Attribute | Details |
| Market Size Value in 2022 | US$ 29.83 billion |
| Revenue Forecast in 2031 | US$ 54.37 billion |
| CAGR | 6.9% |
| Base Year for Estimation | 2022 |
| Forecast Period | 2023-2031 |
| Historical Year | 2021 |
| Segments Covered | Product, Application, End-user, and Region |
| Regional Scope | North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa |
Market Overview:
The Plasma Fractionation Market plays a pivotal role in the healthcare ecosystem, contributing to the production of life-saving plasma-derived therapies. This market involves the separation and purification of plasma components to create a range of therapeutic products used in the treatment of various medical conditions.
Key Developments Driving Market Dynamics:
- Technological Advancements in Fractionation Processes: Ongoing technological advancements are enhancing the efficiency of plasma fractionation processes. Innovations in separation technologies, chromatography, and filtration methods contribute to the production of high-quality plasma-derived therapies.
- Diversification of Therapeutic Products: The market is experiencing diversification in the range of therapeutic products derived from plasma. This includes immunoglobulins, clotting factors, albumin, and other specialty products, catering to a broad spectrum of medical conditions.
- Focus on Quality and Safety Standards: Quality and safety standards are paramount in plasma fractionation. The market is focused on adhering to rigorous regulatory requirements and implementing advanced manufacturing practices to ensure the safety and efficacy of plasma-derived therapies.
Market Segmentation:
Product: Immunoglobulin
Application: Neurology, Hematology
End-user: Hospitals & Clinics
Challenges and Opportunities:
- Supply Chain Management: Managing the supply chain for plasma and plasma-derived products poses challenges. Opportunities for advancements include the development of robust supply chain strategies and collaborations to ensure global accessibility.
- Emerging Markets and Affordability: Ensuring affordability and accessibility, especially in emerging markets, is a challenge. Opportunities exist for initiatives that address economic barriers and facilitate the equitable distribution of plasma-derived therapies.
- Research and Development: Opportunities for advancements lie in ongoing research and development efforts to discover new therapeutic uses for plasma-derived products. Collaborations between industry and research institutions contribute to expanding the therapeutic landscape.
Table of Content
- INTRODUCTION
- Market Ecosystem
- Timeline Under Consideration
- Historical Years – 2021
- Base Year – 2022
- Forecast Years – 2023 to 2031
- Currency Used in the Report
- RESEARCH METHODOLOGY
- Research Approach
- Data Collection Methodology
- Data Sources
- Secondary Sources
- Primary Sources
- Market Estimation Approach
- Bottom Up
- Top Down
- Market Forecasting Model
- Limitations and Assumptions
- PREMIUM INSIGHTS
- Current Market Trends (COVID-19 Perspective)
- Key Players & Competitive Positioning (2022)
- MARKET DYNAMICS
- Drivers
- Restraints
- Opportunities
- GLOBAL PLASMA FRACTIONATION MARKET - ANALYSIS & FORECAST, BY PRODUCT
- Albumin
- Immunoglobulin
- Intravenous Immunoglobulin
- Subcutaneous Immunoglobulin
- Coagulation Factors
- Factor IX
- Factor VIII
- Prothrombin Complex Concentrates
- Fibrinogen Concentrates
- Others
- Protease Inhibitors
- Others
- GLOBAL PLASMA FRACTIONATION MARKET - ANALYSIS & FORECAST, BY APPLICATION
- Immunology
- Neurology
- Hematology
- Critical Care
- Pulmonology
- Others
- GLOBAL PLASMA FRACTIONATION MARKET - ANALYSIS & FORECAST, BY END-USER
- Hospitals & Clinics
- Clinical Research Laboratories
- Others
VALUE PROPOSITIONS RELATED TO THE REPORT:
- Powered with Complimentary Analyst Hours and Expert Interviews with Each Report
- Comprehensive quantitative and qualitative insights at segment and sub-segment level
- Covid 19 impact trends and perspective
- Granular insights at global/regional/country level
- Deep-rooted insights on market dynamics (drivers, restraints, opportunities) and business environment
- Blanket coverage on competitive landscape
- Winning imperatives
- Exhaustive coverage on 'Strategic Developments' registered by leading players of the market
CUSTOMIZATION OPTIONS:
- Distributor Landscape Assessment
- Pricing Intelligence
- Customer Base Assessment
- Investment & Initiatives Analysis
- 'Business Profile' of Key Players
Buy this Premium Research Report: https://www.growthplusreports.com/checkout-8505
Future Outlook:
The Plasma Fractionation Market is poised for continuous growth and innovation as the industry focuses on research, technological advancements, and a commitment to providing life-saving therapies. The market anticipates transformative changes in plasma fractionation processes to meet evolving healthcare needs.
Browse other reports:
The global ambulatory surgical centers market was pegged at US$ 89.5 billion in 2021 and is expected to witness a CAGR of 6.5% during the forecast period.
According to the deep-dive market assessment study by Growth Plus Reports, the global aesthetic lasers and energy devices market was valued at US$ 3.7 billion in 2021 and is expected to register a revenue CAGR of 10% to reach US$ 8.8 billion by 2030.
The global bone growth stimulators market was pegged at US$ 1.7 billion in 2021 and is expected to witness a CAGR of 4.60% during the forecast period.
The global hyaluronic acid-based dermal fillers market was pegged at US$ 4.2 billion in 2021 and is expected to witness a CAGR of 7.60% during the forecast period.
The global injectable drug delivery market was pegged at US$ 546.07 billion in 2021 and is expected to witness a CAGR of 13% during the forecast period from 2022 to 2030.
About Us:
Growth Plus Reports is part of GRG Health, a global healthcare knowledge service company. We are proud members of EPhMRA (European Pharmaceutical Marketing Research Association).
Growth Plus portfolio of services draws on our core capabilities of secondary & primary research, market modelling & forecasting, benchmarking, analysis and strategy formulation to help clients create scalable, ground-breaking solutions that prepare them for future growth and success.
We were awarded by the prestigious CEO Magazine as "Most Innovative Healthcare Market Research Company in 2020.
